The Clorox Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLX research report →
Range $74 – $99
Price Chart
About the company
The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley.
- CEO
- Linda J. Rendle
- IPO
- 1983
- Employees
- 9,200
- HQ
- Oakland, CA, US
Get TickerSpark's AI analysis on CLX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.05B
- P/E
- 19.22
- Fwd P/E
- 18.85
- PEG
- -1.43
- P/S
- 1.80
- P/B
- -333.24
- EV/EBITDA
- 13.94
- Div Yield
- 4.66%
- Gross Margin
- 41.94%
- Op Margin
- 25.06%
- Net Margin
- 9.41%
- ROE
- -1920.57%
- ROIC
- 22.80%
Latest fiscal year · YoY change
- Revenue
- $6.72B-5.4%
- Gross Profit
- $2.84B-11.5%
- Op Income
- $1.66B
- Net Income
- $587.00M-27.5%
- EPS
- $4.82-26.5%
- OCF Growth
- -37.6%
- FCF Growth
- -46.8%
- 52W High
- $128.90
- 52W Low
- $79.12
- 50D MA
- $88.19
- 200D MA
- $99.31
- Beta
- 0.58
- RSI (14)
- 81
- Avg Volume
- 3.12M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Clorox said fiscal Q1 started better than expected, with improving organic sales and share, but the company raised its full-year inflation outlook and expects margin recovery to lean on productivity, RGM and selective pricing.· November 2, 2026
- Q1 came in better than expected, helped by strong execution and some favorable timing benefits.
- Input cost inflation is now expected to be about $240 million for the fiscal year, about $40 million more than planned, with pressure from commodities, transportation and logistics.
- Full-year organic sales growth is guided to 3.5% to 4.5%, including about 3.5 points from lapping the ERP transition; excluding ERP, that implies flat to +1%.
- Management expects organic sales to be slightly down in the first half and slightly up in the second half, with gross margin stronger in the back half.
- Share trends improved in several businesses, while Litter remains a drag and Kingsford remains event-dependent.
Clorox did not give quarterly revenue or EPS figures in the call transcript. Management said fiscal Q1 was better than expected and that first-quarter cost savings were one of the highest quarterly levels on record. Full-year input cost inflation is now expected to be about $240 million, about $40 million above the start-of-year view, and Brent is assumed at about $100 per barrel. Full-year organic sales growth is expected to be 3.5% to 4.5%, including about 3.5 points of ERP-lap benefit, which implies flat to +1% excluding ERP. Management said gross margin will be under pressure on average for the full year, but should be much stronger exiting the year, with the back half higher than the front half.
Linda Rendle said the company is focused on steadily improving performance, market share and superiority while navigating a challenging environment with value-seeking consumers, elevated competition and higher commodity and transportation costs. She highlighted progress in innovation, portfolio evolution, GOJO integration and transformation work moving from investment toward optimization and value creation. Her tone was constructive but cautious: she repeatedly stressed that Clorox is encouraged by the start to the year, yet the operating environment remains volatile and uncertain.
Luc Bellet said the company now expects about $240 million of input cost inflation for fiscal 2027, about $40 million above the initial plan, driven by a broader set of commodities plus transportation and supplier/logistics costs. He said the majority of margin recovery will still come from productivity and cost savings, with targeted pricing and RGM also contributing, and noted first-quarter cost savings were one of the highest quarterly levels on record. Bellet also said Clorox has line of sight to the full $50 million GOJO cost synergy target and may capture some of it earlier than originally expected, supporting a stronger gross margin exit rate in the second half.
Analysts focused on the higher commodity outlook, the phasing of inflation and margin recovery, and whether the company would need more pricing. Management said inflation will be more pronounced in the first half, while mitigation actions will ramp in the second half, and that pricing would remain targeted rather than broad-based unless the environment worsens. Analysts also pressed on share gains and the need for a “rebase”; management said share is improving across several categories, but Litter still needs more work, and the company is not yet at “escape velocity.”
The bull case from the call is that Clorox is seeing sequential improvement in organic sales, retail consumption and share after a noisy ERP year. Management pointed to strong share gains in Home Care, Brita, Hidden Valley and Kingsford, plus a stronger innovation calendar in the back half and faster-than-expected GOJO synergy progress.
The bear case is that cost inflation is rising faster than expected, with about $240 million of input cost pressure and only partial mitigation in the first half. Consumer value-seeking, competitive intensity and weak Litter performance remain headwinds, and management acknowledged that gross margin will be pressured on average this year even though it should improve by year-end.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.8%
- Shares Outstanding
- 120.94M
- Float Shares
- 120.71M
of shares held by institutions
1,104 13F filers
Buy/sell ratio 0.54. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CLX, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Sell | May 15, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Dec 19, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Nov 12, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Oct 31, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Oct 30, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Oct 30, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 29, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Aug 26, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Jun 24, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | Apr 11, 25 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Buy | Apr 29, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Mar 20, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Nov 3, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 15.68M | ▼ 54.68K |
| Blackrock, Inc. | 10.04M | ▼ 127.45K |
| State Street Corp | 8.43M | ▲ 177.95K |
| Vanguard Capital Management LLC | 7.90M | ▲ 45.95K |
| Invesco Ltd. | 6.01M | ▲ 1.15M |
| Vanguard Portfolio Management LLC | 5.80M | ▲ 15.36K |
| Geode Capital Management, LLC | 3.27M | ▲ 36.87K |
| Van Eck Associates Corp | 2.97M | ▼ 245.43K |
| Morgan Stanley | 2.25M | ▼ 469.23K |
| Millennium Management LLC | 2.07M | ▲ 1.38M |
| Beutel, Goodman & Co Ltd. | 2.01M | ▲ 2.01M |
| Ubs Group AG | 1.98M | ▲ 1.07M |
Held by 943 ETFs
Biggest fund positions in CLX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 4, 26 | Breber Pierre R | buy | 4,000 |
| Oct 5, 26 | Rendle Linda J | other | 29,352 |
| Oct 5, 26 | Rendle Linda J | other | 692 |
| Oct 5, 26 | Rendle Linda J | other | 11,989 |
| Oct 5, 26 | Peck Laurene E | other | 1,172 |
| Oct 5, 26 | Peck Laurene E | other | 30 |
| Oct 5, 26 | Peck Laurene E | other | 339 |
| Oct 5, 26 | Marriner Kirsten | other | 6,637 |
| Oct 5, 26 | Marriner Kirsten | other | 1,951 |
| Oct 5, 26 | Marriner Kirsten | other | 2,142 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CLX coverage
Recent articles, reports, and earnings notes.

Clorox (CLX): Execution Risk vs. Brand Strength
Clorox remains a durable branded-staples name, but flat revenue, higher debt, and a difficult ERP transition keep the stock in Hold territory. Household and International are improving, yet Fresh Step and Food remain key execution challenges.

Clorox (CLX): ERP Reset Masks a Fairly Priced Recovery
Clorox rebuilt profitability in fiscal 2025, but FY2026 guidance was cut sharply as ERP-related inventory drawdown hit sales and margins. The stock looks like a steady staples franchise in repair, with valuation close to fair and upside tied to execution.

The Clorox Company (CLX) drops 9% on profit outlook cut
The Clorox Company (CLX) drops sharply after cutting full-year profit guidance and warning that gross margins will weaken more than expected. The consumer staples name posted a mixed quarter, but investors are focusing on lower earnings power, margin pressure, and a tougher near-term outlook.
Want a deeper read on CLX?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
The Clorox Company $CLX Shares Acquired by Commonwealth Equity Services LLC
defenseworld.net · Nov 12
Nasdaq Pops 464 Points as Tech Rally Builds
schaeffersresearch.com · Nov 11
3 Magnificent High-Yield Dividend Stocks to Buy Near Their 52-Week Lows
fool.com · Nov 9
GTA Owner Take-Two, ExxonMobil, Clorox And A Financial Stock On CNBC's ‘Final Trades'
benzinga.com · Nov 9
Analyzing Clorox (NYSE:CLX) & Reynolds Consumer Products (NASDAQ:REYN)
defenseworld.net · Nov 6
3 High-Yielding Dividend Stocks That Investors Can Safely Buy and Hold for Decades
fool.com · Nov 5
Clorox vs. PepsiCo: Which Dividend Stock Could Make You Richer Over the Next 10 Years?
fool.com · Nov 4
The Clorox Company $CLX Stock Sold by Asset Management One Co. Ltd.
defenseworld.net · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.